[Form 4] Blue Ridge Bankshares, Inc. Insider Trading Activity
Insider transaction disclosure: Otis Jones, identified as a director of Blue Ridge Bankshares, Inc. (BRBS), was reported to have acquired 3,434 shares of the issuer's common stock on 09/08/2025 at a recorded price of $4.17 per share. Following this transaction, Mr. Jones beneficially owns 15,929 shares. The Form 4 states these shares were received in lieu of cash compensation and are restricted stock subject to a vesting schedule, indicating the shares are not fully transferable until vesting conditions are met. The filing was signed by an attorney-in-fact on 09/17/2025.
Comunicazione di operazione di insider: Otis Jones, indicato come amministratore di Blue Ridge Bankshares, Inc. (BRBS), ha acquistato 3.434 azioni dell'azione ordinaria della società il 08/09/2025 ad un prezzo registrato di $4,17 per azione. Dopo questa operazione, il sig. Jones detiene in via beneficiaria 15.929 azioni. Il Modulo 4 specifica che tali azioni sono state ricevute in sostituzione del compenso in contanti e sono azioni vincolate soggette a un piano di maturazione, il che significa che non sono trasferibili fino al soddisfacimento delle condizioni di vesting. La dichiarazione è stata firmata da un procuratore il 17/09/2025.
Divulgación de operación de un insider: Otis Jones, identificado como director de Blue Ridge Bankshares, Inc. (BRBS), reportó haber adquirido 3.434 acciones del capital social ordinario de la emisora el 08/09/2025 a un precio registrado de $4,17 por acción. Tras esta transacción, el Sr. Jones posee beneficiariamente 15.929 acciones. El Formulario 4 indica que estas acciones fueron recibidas en lugar de compensación en efectivo y son acciones restringidas sujetas a un calendario de consolidación, lo que implica que no son totalmente transferibles hasta que se cumplan las condiciones de vesting. El documento fue firmado por un apoderado el 17/09/2025.
임원 거래 공개: Blue Ridge Bankshares, Inc.(BRBS)의 이사로 확인된 Otis Jones는 발행회사의 보통주 3,434주를 취득한 것으로 보고되었으며, 취득일은 2025/09/08이고 기록된 가격은 주당 $4.17입니다. 이 거래 후 Jones 씨는 실질적으로 15,929주를 보유하게 됩니다. 제출된 Form 4에는 이 주식들이 현금 보수 대신 수령된 것이며 베스팅 일정이 적용되는 제한주라고 명시되어 있어, 베스팅 요건이 충족될 때까지 완전한 양도가 불가능함을 의미합니다. 제출문서는 2025/09/17에 대리권자에 의해 서명되었습니다.
Divulgation d'une opération d'initié : Otis Jones, identifié comme administrateur de Blue Ridge Bankshares, Inc. (BRBS), a déclaré avoir acquis 3 434 actions des actions ordinaires de l'émetteur le 08/09/2025 à un prix enregistré de 4,17 $ par action. À la suite de cette opération, M. Jones détient à titre bénéficiaire 15 929 actions. Le formulaire 4 précise que ces actions ont été reçues en lieu et place d'une rémunération en espèces et sont des actions restreintes soumises à un calendrier d'acquisition (vesting), ce qui signifie qu'elles ne sont pas entièrement transférables tant que les conditions de vesting ne sont pas remplies. Le dépôt a été signé par un mandataire le 17/09/2025.
Insider-Transparenzmeldung: Otis Jones, als Direktor von Blue Ridge Bankshares, Inc. (BRBS) geführt, meldete den Erwerb von 3.434 Aktien der Stammaktien des Emittenten am 08.09.2025 zu einem erfassten Preis von $4,17 je Aktie. Nach dieser Transaktion hält Herr Jones wirtschaftlich 15.929 Aktien. Im Formular 4 heißt es, dass diese Aktien anstelle von Barvergütung erhalten wurden und als eingeschränkte Aktien mit Vesting-Plan ausgewiesen sind, was bedeutet, dass sie bis zum Erreichen der Vesting-Bedingungen nicht vollständig übertragbar sind. Die Einreichung wurde am 17.09.2025 von einem Bevollmächtigten unterzeichnet.
- Director increased equity ownership by 3,434 shares, aligning interests with shareholders
- Shares were granted as compensation, consistent with retention and alignment practices
- Shares are restricted and subject to vesting, limiting immediate transferability or liquidity
- Acquisition was compensation-based, not an open-market purchase, which may carry less signal about personal conviction
Insights
TL;DR: Director received restricted stock as compensation, modestly increasing beneficial ownership but not an open-market purchase.
The reported 3,434-share acquisition at $4.17 per share reflects compensation converted into equity rather than a market purchase, so it signals alignment with shareholder interests through equity pay but carries limited immediate liquidity or voting transfer until vesting. The post-transaction holding of 15,929 shares is relatively small in absolute terms; without outstanding share count or percent ownership disclosed, the filing alone is not material to valuation models. Monitor future Form 4s for open-market buys or changes to vesting that would affect voting power.
TL;DR: Compensation paid in restricted stock is a common governance practice that ties director incentives to long-term performance.
Receiving restricted stock in lieu of cash is a governance-aligned practice intended to retain directors and align incentives with shareholders. The filing explicitly notes vesting restrictions, which supports retention and long-term alignment but reduces immediate economic disposition. The document is complete for Section 16 reporting: it discloses the transaction date, nature of award, and resulting beneficial ownership. No departures, option exercises, or derivative instruments are reported here.
Comunicazione di operazione di insider: Otis Jones, indicato come amministratore di Blue Ridge Bankshares, Inc. (BRBS), ha acquistato 3.434 azioni dell'azione ordinaria della società il 08/09/2025 ad un prezzo registrato di $4,17 per azione. Dopo questa operazione, il sig. Jones detiene in via beneficiaria 15.929 azioni. Il Modulo 4 specifica che tali azioni sono state ricevute in sostituzione del compenso in contanti e sono azioni vincolate soggette a un piano di maturazione, il che significa che non sono trasferibili fino al soddisfacimento delle condizioni di vesting. La dichiarazione è stata firmata da un procuratore il 17/09/2025.
Divulgación de operación de un insider: Otis Jones, identificado como director de Blue Ridge Bankshares, Inc. (BRBS), reportó haber adquirido 3.434 acciones del capital social ordinario de la emisora el 08/09/2025 a un precio registrado de $4,17 por acción. Tras esta transacción, el Sr. Jones posee beneficiariamente 15.929 acciones. El Formulario 4 indica que estas acciones fueron recibidas en lugar de compensación en efectivo y son acciones restringidas sujetas a un calendario de consolidación, lo que implica que no son totalmente transferibles hasta que se cumplan las condiciones de vesting. El documento fue firmado por un apoderado el 17/09/2025.
임원 거래 공개: Blue Ridge Bankshares, Inc.(BRBS)의 이사로 확인된 Otis Jones는 발행회사의 보통주 3,434주를 취득한 것으로 보고되었으며, 취득일은 2025/09/08이고 기록된 가격은 주당 $4.17입니다. 이 거래 후 Jones 씨는 실질적으로 15,929주를 보유하게 됩니다. 제출된 Form 4에는 이 주식들이 현금 보수 대신 수령된 것이며 베스팅 일정이 적용되는 제한주라고 명시되어 있어, 베스팅 요건이 충족될 때까지 완전한 양도가 불가능함을 의미합니다. 제출문서는 2025/09/17에 대리권자에 의해 서명되었습니다.
Divulgation d'une opération d'initié : Otis Jones, identifié comme administrateur de Blue Ridge Bankshares, Inc. (BRBS), a déclaré avoir acquis 3 434 actions des actions ordinaires de l'émetteur le 08/09/2025 à un prix enregistré de 4,17 $ par action. À la suite de cette opération, M. Jones détient à titre bénéficiaire 15 929 actions. Le formulaire 4 précise que ces actions ont été reçues en lieu et place d'une rémunération en espèces et sont des actions restreintes soumises à un calendrier d'acquisition (vesting), ce qui signifie qu'elles ne sont pas entièrement transférables tant que les conditions de vesting ne sont pas remplies. Le dépôt a été signé par un mandataire le 17/09/2025.
Insider-Transparenzmeldung: Otis Jones, als Direktor von Blue Ridge Bankshares, Inc. (BRBS) geführt, meldete den Erwerb von 3.434 Aktien der Stammaktien des Emittenten am 08.09.2025 zu einem erfassten Preis von $4,17 je Aktie. Nach dieser Transaktion hält Herr Jones wirtschaftlich 15.929 Aktien. Im Formular 4 heißt es, dass diese Aktien anstelle von Barvergütung erhalten wurden und als eingeschränkte Aktien mit Vesting-Plan ausgewiesen sind, was bedeutet, dass sie bis zum Erreichen der Vesting-Bedingungen nicht vollständig übertragbar sind. Die Einreichung wurde am 17.09.2025 von einem Bevollmächtigten unterzeichnet.